SEACOAST BANKING CORP OF FLORIDA — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SEACOAST BANKING CORP OF FLORIDA filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $144.88M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $120.99M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $104.03M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $106.51M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $124.40M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $77.76M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $98.74M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $67.28M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $42.87M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $29.20M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.84B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $15.18B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $14.58B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $12.15B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $9.68B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $8.34B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $7.11B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $6.75B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $5.81B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $4.68B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.79B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $12.99B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $12.47B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $10.54B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $8.37B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $7.21B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $6.12B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $5.88B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $5.12B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $4.25B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.71B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.18B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.11B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $1.61B | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $1.31B | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | $1.13B | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | $985.64M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $864.27M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $689.66M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $435.40M | Feb 27, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 26, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $388.55M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $476.61M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $447.18M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $201.94M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $737.73M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $404.09M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $124.53M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $115.95M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $109.50M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $109.64M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.76M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $106.97M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $106.30M | Feb 25, 2025 |